Cocrystal Pharma

Cocrystal Pharma EBIT Margin

The EBIT Margin (Operating Margin) of Cocrystal Pharma (COCP) as of Oct 31, 2026 is -262.04 %. In the previous year, EBIT Margin (Operating Margin) was -478.65 % — a change of -45.25% (higher).

EBIT Margin

-262.04 %

YoY

-45.25%

Last updated:

EBIT Margin (Operating Margin) of Cocrystal Pharma is 2021 -262.04 % . EBIT Margin (Operating Margin) of Cocrystal Pharma was 2020 -478.65 % . It decreases by -45.25% higher compared to the previous year.

Cocrystal Pharma's operating (EBIT) margin stands at -262.0%, up from -64,433.3% several years earlier.

The Cocrystal Pharma EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2011
-0.31 USD
Jan 1, 2012
-0.15 USD
Jan 1, 2014
-64,433.33 USD
Jan 1, 2015
-69,164.10 USD
Jan 1, 2019
-737.45 USD
Jan 1, 2020
-478.65 USD
Jan 1, 2021
-262.04 USD
The Cocrystal Pharma EBIT Margin history
YEAREBIT MarginYoY
-262.04 %-45.25%
-478.65 %-35.09%
-737.45 %-98.93%
-69,164.10 %+7.34%
-64,433.33 %+42.01 M%
-0.15 %-50.26%
-0.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cocrystal Pharma Stock analysis

What does Cocrystal Pharma do? Cocrystal Pharma Inc, based in Bothell, Washington, is a biotechnology company focused on developing novel antiviral therapeutics. The company specializes in discovering and commercializing treatments for serious viral diseases, including hepatitis C, influenza, and norovirus, using computational methods to design drug candidates. Listed on 12 March 2018, it currently employs 10 full-time staff. Cocrystal Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cocrystal Pharma stock

EBIT Margin (Operating Margin) of Cocrystal Pharma is -262.04 % in 2021.

EBIT Margin (Operating Margin) of Cocrystal Pharma changed from -478.65 % to -262.04 %, representing a -45.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Cocrystal Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Cocrystal Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Cocrystal Pharma

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Cocrystal Pharma